CIK0001764013 — Shareholder Vote
Health Sciences Acquisitions Corporation · 2021-09-09
Approval, on a Non-Binding Advisory Basis, of the Frequency of Future Non-Binding Advisory Votes to Approve the Compensation of Immunovant’s Named Executive Officers
Vote type
other
Outcome
passed
Shares for
82,541,598
Shares against
10,663
Data sourced from SEC EDGAR filings. Dates reflect the vote/event date as disclosed in the filing. Outcomes updated when follow-up filings are published.